What Does Kanna Do? Effects on Mood, Focus & Risks

Kanna is a succulent plant from South Africa that acts as a natural mood-lifter and anxiety reducer. It works through two distinct mechanisms in the brain: blocking the reuptake of serotonin (similar to how common antidepressants work) and inhibiting an enzyme called PDE4, which plays a role in inflammation and mood regulation. This dual action sets it apart from most herbal supplements, which tend to have vague or poorly understood effects.

How Kanna Works in the Brain

Kanna contains four active alkaloids: mesembrine, mesembrenone, mesembrenol, and mesembranol. The most important of these, mesembrine, blocks the serotonin transporter, the same protein targeted by prescription antidepressants like sertraline and fluoxetine. By preventing serotonin from being recycled too quickly, kanna allows more of it to remain active between nerve cells, which generally produces a calming, mood-elevating effect.

The second mechanism, PDE4 inhibition, is less well known but potentially just as important. PDE4 is an enzyme involved in inflammatory signaling within the brain. Blocking it has been linked to improved cognitive function and reduced neuroinflammation. Pharmaceutical companies have spent years developing synthetic PDE4 inhibitors for depression and cognitive decline, so the fact that kanna naturally targets this pathway has drawn significant scientific interest.

Effects on Mood and Anxiety

The most commonly reported effect of kanna is a reduction in anxiety. In a placebo-controlled trial of healthy volunteers taking 25 mg of a standardized kanna extract (Zembrin), participants had significantly lower subjective anxiety levels before a stress test compared to those taking a placebo. Their heart rate responses to stress also differed, suggesting the effect was more than just perception. This was described as the first behavioral evidence supporting kanna’s anxiety-reducing properties in humans.

Neuroimaging research adds another layer. A single 25 mg dose was shown to reduce activity in the amygdala, the brain’s threat-detection center, and alter its connection to the hypothalamus, which controls the stress response. In practical terms, this means kanna appears to dial down the brain’s reactivity to things that would normally trigger worry or tension. Users often describe the feeling as a subtle emotional steadiness rather than sedation or euphoria.

Effects on Thinking and Focus

Kanna’s PDE4 inhibition appears to sharpen certain types of thinking. In a randomized, double-blind, placebo-controlled study of 21 adults (average age around 55), taking 25 mg daily for three weeks significantly improved two cognitive domains: cognitive flexibility, meaning the ability to shift between tasks or mental strategies, and executive function, the higher-order thinking involved in planning and decision-making. The effect sizes were large (Cohen’s d of 1.47 and 1.49 respectively), which is notable for a supplement study.

Processing speed also showed a strong effect size of 2.88, though it didn’t reach statistical significance due to the small sample. Psychomotor speed, which reflects how quickly you can physically respond to information, showed a moderate improvement. Memory, both verbal and visual, did not change. So kanna appears to help with how quickly and flexibly you think, not necessarily how much you remember.

EEG studies tell a similar story. At both 25 mg and 50 mg doses, kanna increased certain brainwave patterns in the frontal region during mental tasks like arithmetic. The 50 mg dose produced additional increases in brainwave activity across parietal, occipital, and temporal regions during cognitive performance, suggesting a dose-dependent effect on mental engagement.

Fermented vs. Unfermented Kanna

Traditionally, the indigenous Khoisan people of South Africa fermented kanna before use, and modern research suggests this wasn’t arbitrary. Fermentation dramatically changes the alkaloid profile. Mesembrine, the primary serotonin-active compound, increases from nearly undetectable levels (0 to 1.6 μg/mL) to between 7.4 and 20.8 μg/mL after fermentation. Meanwhile, mesembrenone decreases. The total alkaloid content also rises.

This matters because unfermented kanna is chemically a different product. If you’re buying raw plant material, whether it’s been fermented will significantly affect what you actually experience. Standardized extracts like Zembrin control for this variability, which is why they’re used in clinical research. If you’re using a non-standardized product, fermented kanna will generally be more potent and more closely resemble what’s been studied.

How People Take It

Kanna is available as dried plant material (chewed or brewed as tea), powdered extract in capsules, and sublingual preparations that dissolve under the tongue. The clinical trials that produced measurable results used 25 mg daily of a standardized extract. This is a useful reference point, but it’s important to understand that 25 mg of a concentrated, standardized extract is not the same as 25 mg of raw powder. Raw plant material contains a much lower concentration of active alkaloids, so the amounts used traditionally were considerably larger.

The route of administration also changes the experience. Sublingual use bypasses the digestive system and tends to produce faster, more noticeable onset. Oral capsules take longer to kick in but may produce more sustained effects. Chewing the plant material, the traditional method, falls somewhere in between since some absorption happens through the mouth’s mucous membranes.

Side Effects and Risks

In clinical studies, kanna has been well tolerated at 25 mg daily. Reported side effects include headache, digestive discomfort, fatigue, drowsiness, and difficulty concentrating. These tend to be mild and are not dramatically different from placebo rates in the trials conducted so far.

The more serious concern is combining kanna with other substances that raise serotonin levels. Because kanna blocks serotonin reuptake through the same mechanism as SSRI antidepressants, stacking the two creates a theoretical risk of serotonin syndrome, a potentially dangerous condition caused by excessive serotonin activity. Symptoms include agitation, rapid heartbeat, high blood pressure, muscle twitching, and in severe cases, seizures. If you’re taking any prescription antidepressant, SNRI, MAOI, or other serotonergic medication, combining it with kanna is a meaningful risk, not a minor footnote.

Kanna is sold as a dietary supplement in the United States, which means it is not evaluated by the FDA for safety or efficacy before reaching store shelves. Product quality varies widely. Standardized extracts with verified alkaloid content offer more predictability than bulk powders from unverified sources.